Karen Katrivesis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Karen Katrivesis has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Jennifer Elia
Department of Anesthesiology and Perioperative Care, Division of Critical Care Medicine, University of California, Irvine, Orange, CA
2 shared publicationsBrent Etiz
University of California
1 shared publication- Corey Nelson1 shared publication
Dawn Lombardo
Department of Medicine, Division of Cardiology/Heart Failure, University of California, Irvine, Orange, CA
1 shared publicationDiana Glovaci
Department of Medicine, Division of Cardiology/Heart Failure, University of California, Irvine, Orange, CA
1 shared publicationFabio Sagebin
Department of Surgery, Division of Cardiothoracic Surgery, University of California, Irvine, Orange, CA
1 shared publication
Latest Publications
- Open Access
- 17 August 2022
- Published by Aga Khan University Hospital in Anaesthesia, Pain & Intensive Care
- Vol. 26 (4) , 546-550
A rare case of late onset malignant hyperthermia
A 42-year-old man with neck squamous cell carcinoma underwent awake fiberoptic intubation and tumor resection under general anesthesia. He developed malignant hyperthermia several hours into the surgical procedure. This case highlights malignant hyperthermia’s (MH) variable time course, pathognomonic signs, and the need for rapid diagnosis and treatment. Early recognition and treatment led to rapid resolution of MH. Ongoing discussion of MH is imperative because this disease is often difficult to diagnose early in its time course and may be fatal if not treated expeditiously. Abbreviations: DS - Dantrolene sodium; DSIS - dantrolene sodium injectable suspension; GA - general anesthesia; MH - malignant hyperthermia; EtCO2 - end tidal carbon dioxide; RYR1 - Ryanodine Receptor gene Key words: Anesthesia, General / methods; Dantrolene / therapeutic use; Diagnosis, Differential; Humans; Malignant Hyperthermia / diagnosis; Malignant Hyperthermia / etiology; Malignant Hyperthermia / physiopathology; Malignant Hyperthermia / therapy Citation: Victor R, Kelly R, Cockrill R, Katrivesis K, Nelson C, Rajan G. A rare case of late onset malignant hyperthermia. Anaesth. pain intensive care. 2022;26(4):546-550; DOI: 10.35975/apic.v26i4.1963 Received: November 19, 2021; Reviewed: April 25, 2022; Accepted: July 12. 2022
- 17 August 2022
- Published by Aga Khan University Hospital in Anaesthesia, Pain & Intensive Care
- Vol. 26 (4) , 546-550
Open AccessA rare case of late onset malignant hyperthermia
A 42-year-old man with neck squamous cell carcinoma underwent awake fiberoptic intubation and tumor resection under general anesthesia. He developed malignant hyperthermia several hours into the surgical procedure. This case highlights malignant hyperthermia’s (MH) variable time course, pathognomonic signs, and the need for rapid diagnosis and treatment. Early recognition and treatment led to rapid resolution of MH. Ongoing discussion of MH is imperative because this disease is often difficult to diagnose early in its time course and may be fatal if not treated expeditiously. Abbreviations: DS - Dantrolene sodium; DSIS - dantrolene sodium injectable suspension; GA - general anesthesia; MH - malignant hyperthermia; EtCO2 - end tidal carbon dioxide; RYR1 - Ryanodine Receptor gene Key words: Anesthesia, General / methods; Dantrolene / therapeutic use; Diagnosis, Differential; Humans; Malignant Hyperthermia / diagnosis; Malignant Hyperthermia / etiology; Malignant Hyperthermia / physiopathology; Malignant Hyperthermia / therapy Citation: Victor R, Kelly R, Cockrill R, Katrivesis K, Nelson C, Rajan G. A rare case of late onset malignant hyperthermia. Anaesth. pain intensive care. 2022;26(4):546-550; DOI: 10.35975/apic.v26i4.1963 Received: November 19, 2021; Reviewed: April 25, 2022; Accepted: July 12. 2022